TXG - 10x Genomics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Show:
Income Statement
Balance Sheet
Cash Flow
Annual
Subscribe to Premium to download historical data

Income Statement

All numbers in thousands
Breakdown
ttm
12/31/2019
12/31/2018
12/31/2017
Total Revenue
245,893
245,893
146,313
71,085
Cost of Revenue
61,033
61,033
28,661
10,560
Gross Profit
184,860
184,860
117,652
60,525
Operating Expenses
Research Development
83,097
83,097
109,900
32,164
Selling General and Administrative
130,834
130,834
87,936
46,736
Total Operating Expenses
215,433
215,433
228,416
78,900
Operating Income or Loss
-30,573
-30,573
-110,764
-18,375
Interest Expense
3,079
3,079
2,409
811
Total Other Income/Expenses Net
-186
-186
-249
137
Income Before Tax
-31,033
-31,033
-112,398
-18,741
Income Tax Expense
218
218
87
21
Income from Continuing Operations
-31,251
-31,251
-112,485
-18,762
Net Income
-31,251
-31,251
-112,485
-18,762
Net Income available to common shareholders
-31,251
-31,251
-112,485
-18,762
Basic EPS
-
-
-1.45
-0.23
Diluted EPS
-
-
-1.45
-0.23
Basic Average Shares
-
-
77,495
82,892
Diluted Average Shares
-
-
77,495
82,892
EBITDA
-
-20,888
-106,084
-13,625